Skip to main content
Erschienen in: Acta Neuropathologica 2/2009

Open Access 01.02.2009 | Correspondence

TDP-43 accumulation is common in myopathies with rimmed vacuoles

verfasst von: Benno Küsters, Bas J. A. van Hoeve, Helenius Jurgen Schelhaas, Henk ter Laak, Baziel G. M. van Engelen, Martin Lammens

Erschienen in: Acta Neuropathologica | Ausgabe 2/2009

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
B. Küsters and B. J. A. van Hoeve have contributed equally to this work.
TAR-DNA-binding protein-43 (TDP-43) is a nuclear protein that is thought to play a regulatory role in gene expression. Ubiquitinated TDP-43 is found in cytoplasmic inclusions in motor neuron disease (MND), frontotemporal lobar degeneration (FTLD-TDP), and MND with FTLD [4]. This shared histopathological hallmark led to the classification of a new class of diseases, the TDP-43-proteinopathies [3]. Recently, TDP-43-positive inclusions have been described in skeletal muscle in sporadic inclusion body myositis (sIBM) and in IBM due to mutations in the valosin-containing protein (VCP) [6]. These myopathies are accompanied by vacuolar changes commonly known as rimmed vacuoles (although these vacuoles are morphologically not always rimmed). These characteristic morphological changes are not exclusive to sIBM and IBM with VCP-mutations but are also found in oculopharyngeal muscular dystrophy (OPMD) [2] and distal myopathies with rimmed vacuoles (DMRV), both of which are hereditary myopathies with inclusion bodies. Although DMRV are a genetically heterogeneous group of diseases, the term is often used in the context of the Nonaka myopathy with mutations of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene [5].
We studied whether TDP-43 aggregates were present in muscle biopsies of sIBM, OPMD and DMRV or in myopathies without the mentioned vacuolar changes.
TDP-43 immunostaining was present in some, but not all, rimmed vacuoles and/or basophilic fibers in most biopsies from patients with sIBM (77.8%) and OPMD (83.3%) and in all biopsies from patients with DMRV (one with confirmed GNE mutation) (Table 1). TDP-43 immunostaining was not detected in muscle biopsies from patients with myopathies without vacuolar changes. The pattern of TDP-43 staining was variable: in some biopsies only a single TDP-43 positive inclusion was visible even though more than one rimmed vacuole was present, and in other biopsies multiple TDP-43-positive aggregates were visualized. Both granular and more dot-like aggregates in rimmed vacuoles and basophilic fibers were detected. The morphology of the aggregates was similar in sIBM, OPMD, and DMRV (Fig. 1a–c). Many aggregates also stained positive for ubiquitin (Fig. 1d–f). Occasionally subsarcolemmal TDP-43 staining was present in fibers that did not exhibit rimmed vacuoles or subsarcolemmal basophilia (Fig. 1g).
Table 1
Summarizing results of TDP-43 immunohistochemistry in muscle biopsies
Disease
Numbers of cases (percentage) with TDP-43 positive aggregates
Myopathies with rimmed vacuoles
 Sporadic inclusion body myositis
14/18 (77.8 %)
 Oculopharyngeal muscular dystrophy
5/6 (83.3%)
 Distal myopathy with rimmed vacuoles
3/3 (100%)
Myopathies without rimmed vacuoles
 Dermatomyositis
0/3 (0%)
 Polymyositis
0/5 (0%)
 Metabolic-mitochondrial myopathy
0/5 (0%)
 Neurogenic atrophy
0/4 (0%)
 Facio-scapulo-humeral dystrophy
0/2 (0%)
 Duchennes’s muscular dystrophy
0/3 (0%)
 Becker’s muscular dystrophy
0/1 (0%)
 Congenital central core disease
0/3 (0%)
 Normal biopsy
0/5 (0%)
In conclusion, we confirm the recent data of Weihl et al. [6], showing the presence of TDP-43-positive inclusions in the majority of muscle biopsies from patients with sIBM. However, we found TDP-43-positive aggregates not only in sIBM but also in other vacuolar myopathies. Thus TDP-43-positive aggregates would seem to be a general phenomenon among the myopathies associated with rimmed vacuoles. This suggests that abnormal TDP-43 accumulation is more likely to be a common endpoint of (muscle) cell degeneration rather than a primary pathological mechanism underlying these myopathies. These findings may provide insight into the pathobiological relevance of TDP-43 aggregates in general and extends the list of proteins that are found in inclusion body myopathies [1].

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Askanas V, Engel WK (2008) Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains. Acta Neuropathol 116:583–595PubMedCrossRef Askanas V, Engel WK (2008) Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains. Acta Neuropathol 116:583–595PubMedCrossRef
2.
Zurück zum Zitat Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, Lafreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164–167PubMedCrossRef Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, Lafreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164–167PubMedCrossRef
3.
Zurück zum Zitat Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CLIII, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol 114:5–22PubMedCrossRef Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CLIII, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol 114:5–22PubMedCrossRef
4.
Zurück zum Zitat Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133PubMedCrossRef Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133PubMedCrossRef
5.
Zurück zum Zitat Nishino I, Malicdan MC, Murayama K, Nonaka I, Hayashi YK, Noguchi S (2005) Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol 24:80–83PubMed Nishino I, Malicdan MC, Murayama K, Nonaka I, Hayashi YK, Noguchi S (2005) Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol 24:80–83PubMed
6.
Zurück zum Zitat Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79:1186–1189PubMedCrossRef Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79:1186–1189PubMedCrossRef
Metadaten
Titel
TDP-43 accumulation is common in myopathies with rimmed vacuoles
verfasst von
Benno Küsters
Bas J. A. van Hoeve
Helenius Jurgen Schelhaas
Henk ter Laak
Baziel G. M. van Engelen
Martin Lammens
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 2/2009
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-008-0471-2

Weitere Artikel der Ausgabe 2/2009

Acta Neuropathologica 2/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.